细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2786人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979255, encodeId=9e4219e9255d3, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Cancers：手术和射频消融（RFA）治疗乙肝相关肝细胞癌患者的疗效对比, objectType=article, longId=221582, objectId=504422158293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=504422158293, replyNumber=0, likeNumber=76, createdTime=2022-10-28, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=504422158293, moduleTitle=Cancers：手术和射频消融（RFA）治疗乙肝相关肝细胞癌患者的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=504422158293)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979295, encodeId=267b19e92953b, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatology：肝细胞癌根治性肝切除术后复发的动态风险预测, objectType=article, longId=299224, objectId=f89e299224e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f89e299224e6, replyNumber=0, likeNumber=85, createdTime=2022-03-02, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f89e299224e6, moduleTitle=Hepatology：肝细胞癌根治性肝切除术后复发的动态风险预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f89e299224e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979274, encodeId=6a5619e9274a5, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后, objectType=article, longId=294048, objectId=4fc429404878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc429404878, replyNumber=0, likeNumber=72, createdTime=2022-08-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc429404878, moduleTitle=BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fc429404878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979203, encodeId=b79619e9203cc, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAMA Oncol：Ivosidenib (AG-120)可改善经治IDH1突变肝内胆管细胞癌患者的总生存：III期ClarIDHy研究最终OS分析结果, objectType=article, longId=217781, objectId=606a21e7812d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=606a21e7812d, replyNumber=0, likeNumber=55, createdTime=2022-08-31, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=606a21e7812d, moduleTitle=JAMA Oncol：Ivosidenib (AG-120)可改善经治IDH1突变肝内胆管细胞癌患者的总生存：III期ClarIDHy研究最终OS分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=606a21e7812d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979242, encodeId=a88919e9242da, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：SMART+顺铂（CDDP）/S1治疗老年食管鳞状细胞癌（ESCC）患者的疗效和安全性, objectType=article, longId=221107, objectId=ae7022110e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae7022110e3c, replyNumber=0, likeNumber=61, createdTime=2022-10-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae7022110e3c, moduleTitle=Front Oncol：SMART+顺铂（CDDP）/S1治疗老年食管鳞状细胞癌（ESCC）患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae7022110e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979234, encodeId=d5b419e923408, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Hepatobiliary Surg Nutr：高HbA1c是肝切除术后并发症的危险因素，并对无肝炎感染的肝细胞癌产生影响, objectType=article, longId=220051, objectId=16f22200518c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16f22200518c, replyNumber=0, likeNumber=79, createdTime=2022-09-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16f22200518c, moduleTitle=Hepatobiliary Surg Nutr：高HbA1c是肝切除术后并发症的危险因素，并对无肝炎感染的肝细胞癌产生影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16f22200518c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979201, encodeId=c9ab19e920117, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性, objectType=article, longId=217734, objectId=763321e734eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763321e734eb, replyNumber=0, likeNumber=81, createdTime=2022-06-15, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763321e734eb, moduleTitle=JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763321e734eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979236, encodeId=17b719e923605, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：包括抗血管抑制剂，PD-1抑制剂以及肝动脉灌注化疗（HAIC）的三联疗法治疗初始不可切除肝细胞癌时手术转化能力的回顾性评估, objectType=article, longId=220296, objectId=ddf8220296a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf8220296a1, replyNumber=0, likeNumber=66, createdTime=2022-04-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf8220296a1, moduleTitle=Front Oncol：包括抗血管抑制剂，PD-1抑制剂以及肝动脉灌注化疗（HAIC）的三联疗法治疗初始不可切除肝细胞癌时手术转化能力的回顾性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf8220296a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979283, encodeId=c95419e92830e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后, objectType=article, longId=295066, objectId=890729506606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=890729506606, replyNumber=0, likeNumber=66, createdTime=2022-07-20, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=890729506606, moduleTitle=Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=890729506606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979309, encodeId=fe5519e93097d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Dermatology：超声鉴别皮肤基底细胞癌形态特征和厚度的研究, objectType=article, longId=301727, objectId=c999301e27be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c999301e27be, replyNumber=0, likeNumber=74, createdTime=2023-02-06, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c999301e27be, moduleTitle=Dermatology：超声鉴别皮肤基底细胞癌形态特征和厚度的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c999301e27be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979273, encodeId=742c19e927326, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=J Immunother Cancer：PD-1抑制剂联合化疗新辅助治疗可切除食管鳞状细胞癌患者的疗效, objectType=article, longId=293994, objectId=aefe293994fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aefe293994fa, replyNumber=0, likeNumber=90, createdTime=2022-01-26, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aefe293994fa, moduleTitle=J Immunother Cancer：PD-1抑制剂联合化疗新辅助治疗可切除食管鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aefe293994fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979241, encodeId=d72f19e924178, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：大剂量IL-2联合立体定向消融放疗治疗转移性肾细胞癌的疗效, objectType=article, longId=220861, objectId=4919220861ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4919220861ca, replyNumber=0, likeNumber=73, createdTime=2022-05-19, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4919220861ca, moduleTitle=Clin Cancer Res：大剂量IL-2联合立体定向消融放疗治疗转移性肾细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4919220861ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979332, encodeId=a1dc19e9332dd, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效, objectType=article, longId=726452, objectId=a4efe2645295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4efe2645295, replyNumber=0, likeNumber=67, createdTime=2022-12-14, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4efe2645295, moduleTitle=BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4efe2645295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979209, encodeId=9f8119e920988, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：肝细胞癌患者早期抗生素暴露反而更有可能从免疫治疗中获益, objectType=article, longId=218268, objectId=23ce21826849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23ce21826849, replyNumber=0, likeNumber=77, createdTime=2022-08-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23ce21826849, moduleTitle=Liver Cancer：肝细胞癌患者早期抗生素暴露反而更有可能从免疫治疗中获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23ce21826849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979342, encodeId=18cd19e934263, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=2022 ASCO：通过个性化和肿瘤知情的ctDNA检测监测肝细胞癌患者肝脏移植后疾病复发的可行性, objectType=article, longId=728361, objectId=4a1be2836132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a1be2836132, replyNumber=0, likeNumber=78, createdTime=2022-07-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a1be2836132, moduleTitle=2022 ASCO：通过个性化和肿瘤知情的ctDNA检测监测肝细胞癌患者肝脏移植后疾病复发的可行性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a1be2836132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979191, encodeId=96e119e9191f3, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAMA：卡瑞丽珠单抗联合化疗一线治疗明显改善晚期食管鳞状细胞癌患者的预后：3期临床研究ESCORT-1st, objectType=article, longId=217175, objectId=e7b321e1759e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7b321e1759e, replyNumber=0, likeNumber=65, createdTime=2021-10-25, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7b321e1759e, moduleTitle=JAMA：卡瑞丽珠单抗联合化疗一线治疗明显改善晚期食管鳞状细胞癌患者的预后：3期临床研究ESCORT-1st, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7b321e1759e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979341, encodeId=fa6c19e9341ec, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=ASCO 2022速递：晚期肾细胞癌患者的健康相关生活质量和临床结果有关吗？, objectType=article, longId=728465, objectId=896be284651f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896be284651f, replyNumber=0, likeNumber=85, createdTime=2023-03-27, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896be284651f, moduleTitle=ASCO 2022速递：晚期肾细胞癌患者的健康相关生活质量和临床结果有关吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896be284651f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979256, encodeId=8f0a19e925600, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌 , objectType=article, longId=221637, objectId=357d22163ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=357d22163ea7, replyNumber=0, likeNumber=64, createdTime=2022-08-28, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=357d22163ea7, moduleTitle=Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=357d22163ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979352, encodeId=806919e9352c1, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：局部晚期头颈部鳞状细胞癌的新辅助化疗+免疫治疗, objectType=article, longId=731133, objectId=8c55e311334c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c55e311334c, replyNumber=0, likeNumber=106, createdTime=2022-10-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c55e311334c, moduleTitle=Clin Cancer Res：局部晚期头颈部鳞状细胞癌的新辅助化疗+免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c55e311334c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979299, encodeId=811619e92998a, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：AFP早期应答与仑伐替尼治疗HBV相关肝细胞癌生存相关, objectType=article, longId=299322, objectId=7c1e299322c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c1e299322c1, replyNumber=0, likeNumber=55, createdTime=2022-08-02, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c1e299322c1, moduleTitle=Front Oncol：AFP早期应答与仑伐替尼治疗HBV相关肝细胞癌生存相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c1e299322c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Cancers：手术和射频消融（RFA）治疗乙肝相关肝细胞癌患者的疗效对比

2022-10-28

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatology：肝细胞癌根治性肝切除术后复发的动态风险预测

2022-03-02

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后

2022-08-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAMA Oncol：Ivosidenib (AG-120)可改善经治IDH1突变肝内胆管细胞癌患者的总生存：III期ClarIDHy研究最终OS分析结果

2022-08-31

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：SMART+顺铂（CDDP）/S1治疗老年食管鳞状细胞癌（ESCC）患者的疗效和安全性

2022-10-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Hepatobiliary Surg Nutr：高HbA1c是肝切除术后并发症的危险因素，并对无肝炎感染的肝细胞癌产生影响

2022-09-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAAD:短期口服vismodegib治疗高危或局部晚期基底细胞癌的各种组织学亚型的疗效、肿瘤反应率和安全性

2022-06-15

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：包括抗血管抑制剂，PD-1抑制剂以及肝动脉灌注化疗（HAIC）的三联疗法治疗初始不可切除肝细胞癌时手术转化能力的回顾性评估

2022-04-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：TACE联合AC（阿帕替尼+卡瑞利珠单抗）较AC治疗改善不可切除肝细胞癌（HCC）患者的预后

2022-07-20

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Dermatology：超声鉴别皮肤基底细胞癌形态特征和厚度的研究

2023-02-06

qingting (审核中...)

前往app查看评论内容

#细胞癌#

J Immunother Cancer：PD-1抑制剂联合化疗新辅助治疗可切除食管鳞状细胞癌患者的疗效

2022-01-26

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：大剂量IL-2联合立体定向消融放疗治疗转移性肾细胞癌的疗效

2022-05-19

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Cancer：BCLC B期肝细胞癌（HCC）患者初始使用仑伐替尼治疗的疗效

2022-12-14

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：肝细胞癌患者早期抗生素暴露反而更有可能从免疫治疗中获益

2022-08-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

2022 ASCO：通过个性化和肿瘤知情的ctDNA检测监测肝细胞癌患者肝脏移植后疾病复发的可行性

2022-07-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAMA：卡瑞丽珠单抗联合化疗一线治疗明显改善晚期食管鳞状细胞癌患者的预后：3期临床研究ESCORT-1st

2021-10-25

qingting (审核中...)

前往app查看评论内容

#细胞癌#

ASCO 2022速递：晚期肾细胞癌患者的健康相关生活质量和临床结果有关吗？

2023-03-27

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌

2022-08-28

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：局部晚期头颈部鳞状细胞癌的新辅助化疗+免疫治疗

2022-10-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：AFP早期应答与仑伐替尼治疗HBV相关肝细胞癌生存相关

2022-08-02

科室
- - 订阅+
  - 更多科室
工具
服务